| BACHEM N -B- | 381.00 / -1.93% |
| Date/Time | 01/15 / 17:31 |
| Chg. / Chg.(%) | -7.50 / -1.93% |
| Bid | - / 32 |
| Ask | 386.00 / 234 |
| Open | 387.50 |
| Previous Close | 388.50 |
| High | 387.50 |
| Low | 375.00 |
| Volume [CHF] | 6,835,297.75 |
| Volume [Units] | 17,930 |
| Price fixings | 777 |
| ISIN | CH0012530207 |
| Security | BANB |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 348.50 |  |
|
| SIX Swiss Ex.. | 381.00 |  |
17,930 |
| London Inter.. | 381.00 | |
57 |
| Nasdaq Other.. | 418.0000 | 48 | |
| Cboe Europe .. | 129.20 | 126 | |
| Cboe Europe .. | 128.80 | 58 | |
| Turquoise | 128.80 | |
13 |
| Frankfurt | 115.0000 | 0 | |
| Berlin | 116.20 | 0 | |
| München | 114.80 | 0 | |
| Hamburg | 114.80 | 0 | |
| EUREX | Options | ||
News
- Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome
05/14/2020 / 07:00 - GlobeNewswire - Generex Biotechnology Initiates Peptide Manufacturing for Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic
05/04/2020 / 14:30 - GlobeNewswire - Generex Subsidiary NuGenerex Immuno-Oncology Announces Publication of Positive Results of the AE37 Phase IIb Breast Cancer Trial
04/28/2020 / 15:24 - GlobeNewswire - Vaccine Contract Manufacturing Market, 2030 - Market is Anticipated to Generate Revenues Worth USD 100 Billion by 2025
10/04/2019 / 10:05 - GlobeNewswire - Global Pharmaceutical Contract Manufacturing Market 2018-2025 - Patent Expiration Of Small Molecules Drugs & Advanced Technologies In API And FDF Manufacturing
03/26/2019 / 10:57 - GlobeNewswire
Real-time